Tezepelumab (Tezspire®), a new treatment for severe asthma

Buxeraud, J; Faure, S

Buxeraud, J (通讯作者)，1 Rue Emile Zola, F-87100 Limoges, France.

ACTUALITES PHARMACEUTIQUES, 2023; 62 (630): 11

Abstract

Tezepelumab (Tezspire (R)), a new treatment for severe asthma. A new monoclonal antibody has been launched for the treatment of severe asthma. This is......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索